Noctrix Health, Inc. secures $40 Million Series C financing to commercialize novel device treatment for Restless Legs Syndrome (RLS) 1/16/2024 Category: INVESTMENTS
Wired Italia unveils Angelini Ventures' strategy: leading AI-driven health-tech innovation for the global future of care 1/11/2024 Category: FEATURED IN
Freya Biosciences secures $38 Million funding in one of the largest Series A raises to advance women’s reproductive immunotherapies 12/12/2023 Category: INVESTMENTS
Angelini Ventures CEO Paolo di Giorgio featured on Idee Geniali Podcast: exploring Corporate Venture Capital in the world of startups 12/4/2023 Category: FEATURED IN
Explore Angelini Ventures' journey and its significant impact on the startup ecosystem, through this comprehensive overview by EconomyUp 10/11/2023 Category: FEATURED IN
Angelini Ventures